These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 611965)

  • 21. Renal effects of nitrendipine.
    Ruilope LM
    J Cardiovasc Pharmacol; 1991; 18 Suppl 5():S10-3. PubMed ID: 1725795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Plasma renin activity and plasma aldosterone in essential hypertension: effect of age and diastolic blood pressure].
    Vetter H; Alasso I; Appenheimer M; Weiand H; Stelkens H; Lucas R; Glänzer K; Witassek F; Stumpe KO; Trübestein G; Krück F
    Schweiz Med Wochenschr; 1976 Dec; 106(49):1729-32. PubMed ID: 1013695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An effect of extrarenal beta adrenergic stimulation on the release of renin.
    Reid IA; Schrier RW; Earley LE
    J Clin Invest; 1972 Jul; 51(7):1861-9. PubMed ID: 4402350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of perindopril on renal haemodynamics and natriuresis in essential hypertension.
    Chaignon M; Barrou Z; Ayad M; Lucsko M; Aubert P; Perret L; Guedon J
    J Hypertens Suppl; 1988 Dec; 6(3):S61-4. PubMed ID: 3225690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The multiple factors affecting plasma renin activity in essential hypertension.
    McDonald RH; Corder CN; Vagnucci AH; Shuman J
    Arch Intern Med; 1978 Apr; 138(4):557-61. PubMed ID: 637637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in blood pressure, fluid volumes and glomerular filtration rate during long-term treatment with prizidilol, an antihypertensive drug with combined vasodilatator and beta-adrenoceptor blocking actions.
    Andersen GS; Hartling OJ; Hein HO; Leth A
    Dan Med Bull; 1985 Oct; 32(5):280-3. PubMed ID: 2865088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased urinary aquaporin-2 excretion in response to furosemide in patients with chronic heart failure.
    Starklint J; Bech JN; Nyvad O; Jensen P; Pedersen EB
    Scand J Clin Lab Invest; 2006; 66(1):55-66. PubMed ID: 16464787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood pressure and renal outcomes in patients with kidney infarction and hypertension.
    Paris B; Bobrie G; Rossignol P; Le Coz S; Chedid A; Plouin PF
    J Hypertens; 2006 Aug; 24(8):1649-54. PubMed ID: 16877969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Some aspects of kidney function, the renin-aldosterone system and sympathetic activity in essential hypertension.
    Pedersen EB
    Acta Med Scand Suppl; 1980; 636():1-66. PubMed ID: 6103641
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of furosemide on plasma renin and aldosterone in three subtypes of essential hypertension.
    Cugini P; Serdoz R; Manconi R; Mancini A; Meucci T
    Boll Soc Ital Biol Sper; 1978 Jan; 54(2):111-5. PubMed ID: 737057
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of pindolol (Visken) on blood pressure and plasma renin activity in various forms of hypertension].
    Werning C; Vetter H
    Adv Clin Pharmacol; 1976; 11():54-60. PubMed ID: 1032571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrarenal secretion of renin in the dog: effect of furosemide.
    Bailie MD; Davis LE; Loutzenhiser R
    Am J Physiol; 1973 Feb; 224(2):425-30. PubMed ID: 4346848
    [No Abstract]   [Full Text] [Related]  

  • 33. Influence of furosemide and d-l propranolol on glomerular filtration rate and renin secretion in the rat.
    Bonvalet JP; Menard J
    Pflugers Arch; 1974 Feb; 346(2):107-19. PubMed ID: 4855795
    [No Abstract]   [Full Text] [Related]  

  • 34. Renin secretion after papaverine and furosemide in conscious sheep.
    Blaine EH
    Proc Soc Exp Biol Med; 1977 Feb; 154(2):232-7. PubMed ID: 840860
    [No Abstract]   [Full Text] [Related]  

  • 35. Changes induced by orthostatism in plasma renin activity and natriuresis. Influence of hypertension and renal failure.
    Labeeuw M; Pozet N; Zech P; Vincent M; Hadj Aissa A; Traeger J
    Contrib Nephrol; 1984; 41():38-42. PubMed ID: 6396038
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pathogenesis of essential hypertension with low renin (author's transl)].
    Ooguri K
    Nihon Jinzo Gakkai Shi; 1979 Feb; 21(2):123-34. PubMed ID: 470224
    [No Abstract]   [Full Text] [Related]  

  • 37. [Furosemide stimulation of renin-secretion in essential hypertension].
    Lue BH; Kuo YM; Hsieh BS; Hsieh WC; Yen TS; Chen WY
    Taiwan Yi Xue Hui Za Zhi; 1986 Jan; 85(1):1-7. PubMed ID: 3519847
    [No Abstract]   [Full Text] [Related]  

  • 38. Letter: Renin and filtration fraction in essential hypertension.
    Birkenhäger WH; Brown JJ; Lever AF; Robertson JI; Schalekamp MA
    Lancet; 1975 Jun; 1(7922):1423-4. PubMed ID: 49583
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cyclic AMP and renin secretion following furosemide, beta-sympathicolysis and amitryptiline].
    Zehner J; Klaus D; Klumpp F; Lemke R
    Verh Dtsch Ges Inn Med; 1975; 81():1033-5. PubMed ID: 180717
    [No Abstract]   [Full Text] [Related]  

  • 40. Low renin hypertension--is it a stage of essential hypertension?
    Abe K; Irokawa N; Aoyagi H; Seino M; Yasujima M
    Tohoku J Exp Med; 1977 Apr; 121(4):347-54. PubMed ID: 867421
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.